［1］Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors［J］. Cell, 2006, 126(4): 663-676.
［2］Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors［J］. Cell, 2007, 131(5): 861-872.
［3］Yu J, Vodyanik MA, SmugaOtto K, et al. Induced pluripotent stem cell Lines derived from human somatic cells［J］. Science, 2007,318(5858): 1917-1920.
［4］Di Stefano B, Graf T. Very rapid and efficient generation of induced pluripotent stem cells from mouse Pre-B cells［J］. Methods Mol Biol, 2014 ［Epub ahead of print］.
［5］Merkl C, Saalfrank A, Riesen N, et al. Efficient generation of rat induced pluripotent stem cells using a non-viral inducible vector［J］. PLoS One, 2013, 8(1): e55170.
［6］Shimozawa N. Cynomolgus monkey induced pluripotent stem cells generated by using allogeneic genes［J］. Methods Mol Biol, 2014［Epub ahead of print］.
［7］Fujie Y, Fusaki N, Katayama T, et al. New type of sendai virus vector provides transgenefree iPS cells derived from chimpanzee blood［J］. PLoS One, 2014, 9(12): e113052.［8］Li X, Shan ZY, Wu YS, et al. Generation of neural progenitors from induced Bama miniature pig pluripotent cells［J］. Reproduction, 2014, 147(1): 65-72.
［9］Marchetto MC, Carromeu C, Acab A, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells［J］. Cell, 2010, 143(4): 527-539.
［10］Ikehata H, Masuda T, Sakata H, et al. Analysis of mutation spectra in UVB-exposed mouse skin epidermis and dermis: frequent occurrence of C→T transition at methylated CpG-associated dipyrimidine sites［J］. Environ Mol Mutagen, 2003, 41(4): 280-292.
［11］Yamanaka S. Patient-specific pluripotent stem cells become even more accessible［J］. Cell Stem Cell, 2010, 7(1): 1-2.
［12］Loh YH, Hartung O, Li H, et al. Reprogramming of T cells from human peripheral blood［J］. Cell Stem Cell, 2010, 7(1): 15-19.
［13］Staerk J, Dawlaty MM, Gao Q, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells［J］. Cell Stem Cell, 2010, 7(1): 20-24.
［14］Chou BK, Mali P, Huang X, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures［J］. Cell Res, 2011, 21(3): 518-529.
［15］Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells［J］. Nature, 2010, 467(7313): 285-290.
［16］Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency［J］. Cell, 2008, 133(2): 250-264.
［17］Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53p21 pathway［J］. Nature, 2009, 460(7259): 1132-1135.
［18］Eminli S, Foudi A, Stadtfeld M, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells［J］. Nat Genet, 2009, 41(9): 968-976.
［19］Di Stefano B, Sardina JL, van Oevelen C, et al. C/EBPalpha poises B cells for rapid reprogramming into induced pluripotent stem cells［J］. Nature, 2014, 506(7487): 235-239.［20］Hubbard JJ, Sullivan SK, Mills JA, et al. Efficient iPS cell generation from blood using episomes and HDAC inhibitors［J］. J Vis Exp, 2014,(92): e52009.
［21］Hu K, Yu J, Suknuntha K, et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells［J］. Blood, 2011, 117(14):109-119. 
［22］Su RJ, Neises A, Zhang XB,et al. Generation of iPS cells from human peripheral blood mononuclear cells using episomal vectors［J］. Methods Mol Biol, 2014［Epub ahead of print］.
［23］Seki T, Yuasa S, Oda M, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells［J］. Cell Stem Cell, 2010, 7(1): 11-14.
［24］Merling RK, Sweeney CL, Choi U, et al.Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells［J］.Blood, 2013,121(14):e98-107.
［25］Zhou H, Martinez H, Sun B, et al. Rapid and efficient generation of transgene-free iPSC from a small volume of cryopreserved blood［J］. Stem Cell Rev, 2015, 11(4): 652-665.［26］Ye Z, Zhan H, Mali P, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders［J］. Blood, 2009, 114(27):  5473-5480.
［27］Hiramoto T, Ebihara Y, Mizoguchi Y, et al. Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells［J］. Proc Natl Acad Sci USA, 2013, 110(8): 3023-3028.